Interferon beta-1a Terminated Phase 4 Trials for Relapsing Remitting Multiple Sclerosis (RRMS) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01701856Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis
NCT00574041How Side Effects of Avonex Are Affected by Gradually Increasing to Full Dose vs Starting at Full Dose